» Articles » PMID: 25863674

Axonal Protection by Brimonidine with Modulation of P62 Expression in TNF-induced Optic Nerve Degeneration

Overview
Specialty Ophthalmology
Date 2015 Apr 13
PMID 25863674
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The p62, also called sequestosome 1 (SQSTM1), plays a crucial role in tumor necrosis factor (TNF)-induced optic nerve degeneration. Brimonidine has been shown to have protective effects on retinal ganglion cell bodies, although its role in their axons remains to be examined. We determined whether brimonidine modulates axonal loss induced by TNF and affects the expression of p62 in the optic nerve.

Methods: Experiments were performed on adult male Wistar rats that received an intravitreal injection of 10 ng TNF alone or simultaneous injection of TNF and 2, 20, or 200 pmol of brimonidine tartrate. The expression of p62 in the optic nerve was examined by immunoblot analysis. The effects of brimonidine on axons were evaluated by counting axon numbers 2 weeks after intravitreal injection.

Results: Intravitreal injection of brimonidine exerted substantial axonal protection against TNF-induced optic nerve degeneration. Immunoblot analysis showed that p62 was upregulated in the optic nerve after intravitreal injection of TNF, and that this increase was completely inhibited by brimonidine. Treatment with brimonidine alone also significantly decreased p62 protein levels in the optic nerve compared with the basal level.

Conclusions: These results suggest that the modulation of p62 levels in the optic nerve by brimonidine may be involved partly in its axonal protection.

Citing Articles

Axonal protection by combination of ripasudil and brimonidine with upregulation of p-AMPK in TNF-induced optic nerve degeneration.

Otsubo M, Sase K, Tsukahara C, Fujita N, Arizono I, Tokuda N Int Ophthalmol. 2024; 44(1):173.

PMID: 38598101 PMC: 11006787. DOI: 10.1007/s10792-024-03095-9.


Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.

Lambuk L, Lazaldin M, Ahmad S, Iezhitsa I, Agarwal R, Uskokovic V Front Pharmacol. 2022; 13:875662.

PMID: 35668928 PMC: 9163364. DOI: 10.3389/fphar.2022.875662.


mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury.

Wen Y, Zhang J, Kapupara K, Tsai R Exp Mol Med. 2019; 51(8):1-11.

PMID: 31409770 PMC: 6802655. DOI: 10.1038/s12276-019-0298-z.

References
1.
Prokosch V, Panagis L, Volk G, Dermon C, Thanos S . Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants. Invest Ophthalmol Vis Sci. 2010; 51(12):6688-99. DOI: 10.1167/iovs.09-4835. View

2.
Fujita Y, Sato A, Yamashita T . Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation. Cell Death Dis. 2013; 4:e763. PMC: 3763459. DOI: 10.1038/cddis.2013.298. View

3.
Johansen T, Lamark T . Selective autophagy mediated by autophagic adapter proteins. Autophagy. 2010; 7(3):279-96. PMC: 3060413. DOI: 10.4161/auto.7.3.14487. View

4.
Aviles-Trigueros M, Mayor-Torroglosa S, Garcia-Aviles A, Lafuente M, Rodriguez M, de Imperial J . Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine. Exp Neurol. 2004; 184(2):767-77. DOI: 10.1016/S0014-4886(03)00298-X. View

5.
Kitaoka Y, Hayashi Y, Kumai T, Takeda H, Munemasa Y, Fujino H . Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy. J Neuropathol Exp Neurol. 2009; 68(8):915-27. DOI: 10.1097/NEN.0b013e3181afecfa. View